Sort   by:  
 Page size 
UnknownPhase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas.
Not available
S-EPMC7465458 | biostudies-literature
UnknownSarcocystis caninum and Sarcocystis svanai n. spp. (Apicomplexa: Sarcocystidae) Associated with Severe Myositis and Hepatitis in the Domestic Dog (Canis familiaris).
Not available
S-EPMC4372507 | biostudies-literature
UnknownPhase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma.
Not available
S-EPMC6751592 | biostudies-literature
UnknownObjectively measured physical activity and longitudinal changes in adolescent body fatness: an observational cohort study.
Not available
S-EPMC4780592 | biostudies-literature
UnknownRadiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.
Not available
S-EPMC8051405 | biostudies-literature
UnknownPhase 2 study of pembrolizumab in patients with advanced rare cancers.
Not available
S-EPMC7078933 | biostudies-literature
TranscriptomicsTranscription profiling of three developmental stages of Leishmania major - earlylLog, PNA- metacyclics and mouse lesion derived amastigotes
Comparison of three developmental stages (Early Log, PNA- metacyclics and Mouse lesion Derived Amastigotes) of L.major FV1.
ORGANISM(S): Leishmania major 
2009-10-15 | E-MEXP-1864 | biostudies-arrayexpress
UnknownAltered function and differentiation of age-associated B cells contribute to the female bias in lupus mice.
Not available
S-EPMC8355159 | biostudies-literature
GenomiceMERGE Network Phase III: HRC Imputed Array Data of 83,000+ Participants

The Electronic Medical Records and Genomics (eMERGE) Network is a National Institutes of Health (NIH)-organized and funded consortium of U.S. medical research institutions. The primary goal of the eMERGE Network is to develop, disseminate, and apply approaches to research that combine bioreposito...

phs001584 | dbGaP
ProteomicsA SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Purposing
An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 170,000 people since the end of 2019, killed over 7,400, and caused worldwide social and economic disruption. SARS-CoV-2 infection has a mortality rate of 3.4% among confirmed case...
ORGANISM(S): Severe Acute Respiratory Syndrome Coronavirus 2 (ncbitaxon:2697049) Homo Sapiens (ncbitaxon:9606) 
2020-03-24 | MSV000085144 | MassIVE
Sort   by:  
 Page size